Skip to content

Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases

Gastric- Versus Jejunal Feeding Tubes in Alcoholic Liver Diseases

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02319252
Enrollment
40
Registered
2014-12-18
Start date
2015-01-31
Completion date
2018-04-30
Last updated
2018-04-20

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Liver Diseases, Alcoholic, Malnutrition

Brief summary

The study is an unblinded randomized trial, designed to examine whether gastric- or jejunal feeding tubes are the most effect full to feed patients with alcoholic liver diseases and non-sufficient oral intake. The primary outcome will be differences in nutrition intake between the groups. Secondary outcomes will be: the amount of unplanned tube discontinuations; handgrip and patients' quality of life, nausea & vomiting. The study will include 40 patients at Aarhus University Hospital, Denmark.

Interventions

DEVICEGastric tube (Nutricia Flocare® Pur Tube Enlock)

Nutricia Flocare® Pur Tube Enlock, Ch. 12

DEVICEJejunal tube (Nutricia Flocare® Bengmark®)

Nutricia Flocare® Bengmark®, Ch. 10

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No

Inclusion criteria

* Alcoholic liver disease * nutrition intake less than 75% of needed intake * Signed informed consent form

Exclusion criteria

* Hepatic encephalopathy, grade 3 - 4 * Anatomic barriers to have a tube placed

Design outcomes

Primary

MeasureTime frameDescription
Differences in nutrition intakeDay 3 & 7 and every 7th. day until discharge from the hospital, up to 3 monthsNutrition intake, protein intake, oral intake versus tube intake

Secondary

MeasureTime frameDescription
Differences in patients reported outcomesDay 3 & 7 and every 7th. day until discharge from the hospital, up to 3 monthsQuestionnaires

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026